List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. Asia Pacific Transcriptomics Market, 2021-2031, $ mn 20
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Transcriptomics Market 25
Figure 7. Primary Restraints and Impact Factors of Asia Pacific Transcriptomics Market 30
Figure 8. Investment Opportunity Analysis 34
Figure 9. Porter’s Fiver Forces Analysis of Asia Pacific Transcriptomics Market 37
Figure 10. Breakdown of Asia Pacific Transcriptomics Market by Component, 2021-2031, % of Revenue 42
Figure 11. Asia Pacific Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%) 42
Figure 12. Asia Pacific Transcriptomics Market by Component: Instruments, 2021-2031, $ mn 43
Figure 13. Asia Pacific Transcriptomics Market by Component: Consumables, 2021-2031, $ mn 45
Figure 14. Asia Pacific Transcriptomics Market by Component: Software, 2021-2031, $ mn 47
Figure 15. Asia Pacific Transcriptomics Market by Component: Services, 2021-2031, $ mn 49
Figure 16. Breakdown of Asia Pacific Transcriptomics Market by Technology, 2021-2031, % of Sales Revenue 51
Figure 17. Asia Pacific Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 51
Figure 18. Asia Pacific Transcriptomics Market by Technology: Polymerase Chain Reaction (PCR), 2021-2031, $ mn 52
Figure 19. Asia Pacific Transcriptomics Market by Technology: Next-Generation Sequencing, 2021-2031, $ mn 54
Figure 20. Asia Pacific Transcriptomics Market by Technology: Microarray, 2021-2031, $ mn 56
Figure 21. Asia Pacific Transcriptomics Market by Technology: In-Situ Hybridization (ISH), 2021-2031, $ mn 58
Figure 22. Asia Pacific Transcriptomics Market by Technology: Gene Regulation Technologies, 2021-2031, $ mn 60
Figure 23. Asia Pacific Transcriptomics Market by Technology: Other Technologies, 2021-2031, $ mn 61
Figure 24. Breakdown of Asia Pacific Transcriptomics Market by Application, 2021-2031, % of Sales Revenue 63
Figure 25. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 63
Figure 26. Asia Pacific Transcriptomics Market by Application: Drug Discovery and Development, 2021-2031, $ mn 64
Figure 27. Asia Pacific Transcriptomics Market by Application: Diagnostics, 2021-2031, $ mn 65
Figure 28. Asia Pacific Transcriptomics Market by Application: Single Cell Analysis, 2021-2031, $ mn 66
Figure 29. Asia Pacific Transcriptomics Market by Application: Gene Expression, 2021-2031, $ mn 67
Figure 30. Asia Pacific Transcriptomics Market by Application: Cell Biology, 2021-2031, $ mn 68
Figure 31. Asia Pacific Transcriptomics Market by Application: Other Applications, 2021-2031, $ mn 69
Figure 32. Breakdown of Asia Pacific Transcriptomics Market by End User, 2021-2031, % of Revenue 71
Figure 33. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 71
Figure 34. Asia Pacific Transcriptomics Market by End User: Academic and Research Institutions, 2021-2031, $ mn 72
Figure 35. Asia Pacific Transcriptomics Market by End User: Biotechnology and Biopharmaceutical Companies, 2021-2031, $ mn 73
Figure 36. Asia Pacific Transcriptomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 74
Figure 37. Asia Pacific Transcriptomics Market by End User: Other End Users, 2021-2031, $ mn 75
Figure 38. Breakdown of APAC Transcriptomics Market by Country, 2021 and 2031, % of Revenue 77
Figure 39. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 78
Figure 40. Transcriptomics Market in Japan, 2021-2031, $ mn 80
Figure 41. Transcriptomics Market in China, 2021-2031, $ mn 82
Figure 42. Transcriptomics Market in Australia, 2021-2031, $ mn 84
Figure 43. Transcriptomics Market in India, 2021-2031, $ mn 86
Figure 44. Transcriptomics Market in South Korea, 2021-2031, $ mn 88
Figure 45. Transcriptomics Market in Rest of APAC, 2021-2031, $ mn 90
Figure 46. Growth Stage of Asia Pacific Transcriptomics Industry over the Forecast Period 92
Asia Pacific transcriptomics market will grow by 13.1% annually with a total addressable market cap of $ 29,787.1 million over 2022-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure. Highlighted with 39 tables and 46 figures, this 120-page report “Asia Pacific Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific transcriptomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Country. Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Consumables • Software • Services Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Polymerase Chain Reaction (PCR) • Next-Generation Sequencing • Microarray • In-Situ Hybridization (ISH) • Gene Regulation Technologies • Other Technologies By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Drug Discovery and Development • Diagnostics • Single Cell Analysis • Gene Expression • Cell Biology • Other Applications By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Academic and Research Institutions • Biotechnology and Biopharmaceutical Companies • Contract Research Organizations (CROs) • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Technology and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: 10x Genomics Agilent Technologies, Inc. ANGLE plc Becton, Dickinson and Company (BD) Bio-Rad Laboratories, Inc. BioSypder, Inc. Bio-Techne Cytiva F. Hoffmann-La Roche Ltd. Fluidigm Corporation GE Healthcare Illumina, Inc. Menarini Silicon Biosystems Merck & Co., Inc. NanoString Pacific Biosciences of California, Inc. PerkinElmer Inc. Promega Corporation Qiagen N. V. Takara Bio Inc. Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More